Add BrightSurf on Google Email

Dietary sucrose determines activity of lithium on gene expression and lifespan in drosophila melanogaster

Researchers found that lithium's efficacy in enhancing longevity and altering body composition is influenced by the sucrose content of the diet. The study reveals a significant overlap between the transcriptional responses to increasing dietary sucrose and adding lithium, suggesting a joint mechanism at play.

SourceImpact Journals LLC·JournalAging-US·TypeExperimental study·DateJun 20, 2024

More effective cancer treatment with iontronic pump

Researchers at Linköping University and the Medical University of Graz have developed a new cancer treatment using an iontronic pump to deliver continuous, low-dose chemotherapy directly to brain tumors. This approach significantly reduces tumor growth by bypassing the blood-brain barrier, a common obstacle to effective treatment.

SourceLinköping University·JournalJournal of Controlled Release·TypeExperimental study·DateJun 19, 2024

New study reveals combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients

A new study led by Chapman University researchers found that combining Donepezil and Memantine significantly increased the probability of five-year survival for Alzheimer's disease patients. The combined use of these two medications reduced mortality rates by 0.05, or 6.4%, compared to no treatment and single-drug use.

SourceChapman University·JournalCommunications Medicine·DateJun 12, 2024

FAP-targeted therapy demonstrates significant efficacy in controlling advanced sarcomas

Researchers found that FAP-targeted radioligand therapy controlled disease progression in nearly half of patients with advanced sarcoma, and was well-tolerated without critical organ radiation dose levels being reached. The study's results indicate a promising approach for this patient group with limited treatment options.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJun 8, 2024

Breaking down barriers: ROCK2 inhibition facilitates drug delivery in fibrotic pancreatic cancer

Researchers developed a human pancreatic cancer fibrotic barrier model to assess treatment strategies and test efficacy of therapeutic interventions. Inhibition of ROCK2 pathway resulted in reduced ECM remodeling and improved tissue permeability for drugs, highlighting its potential for enhancing drug delivery in PDAC.

SourceOkayama University·JournalJournal of Controlled Release·TypeExperimental study·DateJun 5, 2024

White blood cell “nets” could be early warning sign of major immunotherapy complication

A study from Michigan Medicine reveals a connection between neutrophil activation and severe cytokine release syndrome (CRS), a potentially life-threatening reaction to CAR T-Cell therapy. Researchers identified biomarkers of NETosis, a process in which neutrophils create webs that may contribute to CRS.

SourceMichigan Medicine - University of Michigan·JournalBlood Advances·TypeExperimental study·DateJun 3, 2024

Optimal cancer-killing t cells discovered

Researchers at the University of Houston have identified a subset of T cells called CD8-fit that show high motility and serial killing capabilities in patients with clinical responses. These cells were discovered using a patented approach called TIMING, which evaluates cell behavior and movement to identify potential cancer-killing cells.

SourceUniversity of Houston·JournalNature Cancer·DateMay 28, 2024

Diagnosis of lymphatic metastasis in breast cancer using nanoparticle technology - diagnosis, therapy, imaging, treatment

Researchers explore nanoparticle-based therapies to specifically target lymphatic metastasis in breast cancer, providing a promising solution for patient treatment. Nanoparticles deliver drugs directly to tumors, targeting cancer cells to destroy them or slow their growth, while also enhancing the immune response.

SourceBentham Science Publishers·JournalThe Open Neuroimaging Journal·DateMay 27, 2024

Drug helps reprogram macrophage immune cells, suppress prostate and bladder tumor growth

A novel therapy has been developed to reprogram macrophage immune cells, shifting their balance toward antitumor activity. The treatment, JHU083, blocks the use of glutamine in tumors, reducing growth and triggering cell death. It also boosts immune-activating macrophages, recruiting tumor-killing T-cells and natural killer cells.

SourceJohns Hopkins Medicine·JournalCancer Immunology Research·DateMay 21, 2024

Few moderate or severe asthma patients prescribed recommended inhaler regimen

Only 14.5% of adult patients with moderate or severe asthma are prescribed the recommended Single Maintenance and Reliever Therapy (SMART) combination inhaler regimen. Older age and Medicare insurance are associated with not being prescribed SMART, suggesting providers may resist changing treatment regimens for these groups.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMay 21, 2024

The beginning of becoming a human

Researchers Polina A. Loseva and Vadim N. Gladyshev challenge the existing definition of human life, suggesting a new meaning for the 14-day stage in organismal life grounded in recent mechanistic advances and insights from aging studies. This stage defines the separation of soma from the germline and marks the boundary between rejuven...

SourceImpact Journals LLC·JournalAging-US·TypeLiterature review·DateMay 9, 2024

Faster approach for starting extended-release naltrexone to treat opioid use disorder shown effective

Starting people with opioid use disorder on extended-release, injectable naltrexone within five to seven days of seeking treatment is more effective than the standard method. This rapid treatment protocol requires closer medical supervision and could make XR-naltrexone a more viable option for treating opioid use disorder.

SourceNIH/National Institute on Drug Abuse·JournalJAMA Network Open·DateMay 8, 2024

First effective treatment found for spitting cobra snakebite

Scientists have found an effective treatment for spitting cobra snakebites by blocking one of the major dermonecrosis-causing toxins with varespladib. The study suggests that this repurposed drug can prevent tissue damage and may become a valuable treatment against black-necked and red spitting cobra venoms.

SourceLancaster University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMay 7, 2024

Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and—eventually—treatment

A massive study identifies new biomarkers for renal cell carcinoma subtypes, improving diagnosis and treatment. The researchers' integrative analysis of proteogenomic datasets reveals molecular features shared by clear cell and non-clear cell RCC tumors, as well as unique features to various subtypes.

SourceMichigan Medicine - University of Michigan·JournalCell Reports Medicine·TypeExperimental study·DateMay 6, 2024

Cover paper: Senescent characteristics of human corneal endothelial cells upon UV-A exposure

Researchers investigate senescence phenotypes of human corneal endothelial cells upon treatment with ultraviolet (UV)-A. Cells exhibit enlarged morphology, increased β-galactosidase activity and decreased proliferation. UV-A-induced senescent cells show similar gene expression profiles to ionizing radiation (IR)-induced cells.

SourceImpact Journals LLC·JournalAging-US·TypeObservational study·DateApr 30, 2024

Targeted use of enfortumab vedotin for the treatment of advanced urothelial carcinoma

A new study published in the Journal of Clinical Oncology identified NECTIN4 amplification as a potential genomic biomarker for predicting treatment response to enfortumab vedotin in patients with advanced urothelial carcinoma. The study found that over 90% of patients with NECTIN4 amplification showed tumor response to EV therapy.

SourceUniversitatsklinikum Bonn·JournalJournal of Clinical Oncology·DateApr 24, 2024

Evidence of a pan-tissue decline in stemness during human aging

Researchers found that ~60% of tissues exhibit a significant negative correlation between age and stemness score, indicating a pan-tissue decline in stemness. This study adds weight to the idea that stem cell deterioration contributes to human aging, with hematopoietic stem cells from older individuals showing higher stemness scores.

SourceImpact Journals LLC·JournalAging-US·TypeObservational study·DateApr 16, 2024

Next-generation treatments hitch a ride into cancer cells

Researchers from Osaka University have discovered a way to deliver antisense oligonucleotides to their targets inside cancer cells by opening specific calcium permeable channels. The new compound, L687, promotes efficient uptake of ASO into cancer cells, suppressing target gene activity and enhancing ASO efficacy.

SourceOsaka University·JournalNucleic Acids Research·TypeExperimental study·DateApr 15, 2024

Targeted liver cancer treatment kills cancer cells and cuts chemo side effects

Researchers have developed a new treatment that uses tailored doses of anti-cancer drugs released directly into the surgical cavity to treat liver cancer. The approach has shown promise in reducing recurrence rates and minimizing chemotherapy side effects, with potential applications for other types of cancer.

SourceUniversity of South Australia·JournalInternational Journal of Pharmaceutics·TypeExperimental study·DateApr 14, 2024

In the drive to deprescribe, heartburn drug study teaches key lessons

A new study shows that a massive effort to reduce the overuse of proton pump inhibitors (PPIs) led to a nearly 30% reduction in prescriptions, but also resulted in some veterans missing out on protective use. The intervention, which imposed limits on PPI prescription size and refills, was carried out in one region of the Veterans Healt...

SourceMichigan Medicine - University of Michigan·JournalBMJ·TypeData/statistical analysis·DateApr 11, 2024